Analysts have branded RSA's ambitious £5bn all-cash bid for the non-life operations of Aviva as "very low" and "puzzling", suggesting it could be a tactical ploy prior to a friendly merger.
Analysts have branded RSA's ambitious £5bn all-cash bid for the non-life operations of Aviva as "very low" and "puzzling", suggesting it could be a tactical ploy prior to a friendly merger.